(Q43524768)

24 November 2017

title

Delayed vomiting in children with cancer after receiving moderately high or highly emetogenic chemotherapy (English)

1 reference

24 November 2017

1 reference

Deborah L Robinson

1

1 reference

24 November 2017

Barbara A Carr

series ordinal

2

1 reference

24 November 2017

publication date

1 March 2007

1 reference

Journal of Pediatric Oncology Nursing

24 November 2017

published in

1 reference

24 November 2017

volume

24

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

70-80

1 reference

Symptom experiences during chemotherapy treatment--with focus on nausea and vomiting

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

Etiology and treatment of the psychological side effects associated with cancer chemotherapy: a critical review and discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

Ondansetron: a review of its use as an antiemetic in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

Delayed nausea and vomiting in children receiving antineoplastics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 St

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

Symptom management research in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

Acute and delayed nausea and emesis control in pediatric oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

Major stressors and their effects on the well-being of children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

Delayed emesis: incidence, pattern, prognostic factors and optimal treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

Anticipatory nausea and emesis, and psychological morbidity: assessment of prevalence among out-patients on mild to moderate chemotherapy regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

Chemotherapy side effects in pediatric oncology patients: Drugs, age, and sex as risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

Can children understand and use a rating scale to quantify somatic symptoms? Assessment of nausea and vomiting as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1043454206298840

21 January 2018

Identifiers

DOI

10.1177/1043454206298840

1 reference

24 November 2017

1 reference